These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27498594)

  • 1. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
    Otsuki M; Kitamura T; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Endocr J; 2016 Nov; 63(11):1017-1023. PubMed ID: 27498594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome.
    Kitamura T; Otsuki M; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Clin Chim Acta; 2013 Sep; 424():164-7. PubMed ID: 23792199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome].
    Takeda N; Yasuda K; Horiya T; Yamada H; Imai T; Kitada M; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):631-48. PubMed ID: 3525245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data mining: The association of 2-h postprandial plasma glucose with the fasting plasma glucose in a large Chinese population.
    Sun D; Li D; Yu S; Zhang K; Cheng X
    J Clin Lab Anal; 2020 Sep; 34(9):e23404. PubMed ID: 32484250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing's disease.
    Faggiano A; Pivonello R; Melis D; Alfieri R; Filippella M; Spagnuolo G; Salvatore F; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Feb; 25(2):142-51. PubMed ID: 11929085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome.
    Kitamura T; Otsuki M; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Bando Y; Shimomura I; Koga M
    Clin Biochem; 2014 Dec; 47(18):279-82. PubMed ID: 25218816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications.
    Ivović M; Marina LV; Vujović S; Tančić-Gajić M; Stojanović M; Radonjić NV; Gajić M; Soldatović I; Micić D
    Metabolism; 2013 Jun; 62(6):786-92. PubMed ID: 23332445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing's syndrome.
    Tsurutani Y; Miyoshi K; Inoue K; Takiguchi T; Saito J; Omura M; Nishikawa T
    Endocr J; 2019 Mar; 66(3):207-214. PubMed ID: 30674738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis.
    Page R; Boolell M; Kalfas A; Sawyer S; Pestell R; Ward G; Alford F
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):509-17. PubMed ID: 1769133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.
    Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
    J Diabetes Complications; 2013; 27(6):593-6. PubMed ID: 23890682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol-binding protein 4 (RBP-4) levels do not change after oral glucose tolerance test and after dexamethasone, but correlate with some indices of insulin resistance in humans.
    Lewandowski KC; Basinska-Lewandowska M; Bieńkiewicz M; Randeva HS; Lewiński A
    Endokrynol Pol; 2008; 59(4):305-11. PubMed ID: 18777500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.
    Fallo F; Scarda A; Sonino N; Paoletta A; Boscaro M; Pagano C; Federspil G; Vettor R
    Eur J Endocrinol; 2004 Mar; 150(3):339-44. PubMed ID: 15012619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.